reproductive-health

BackgroundObstetric fistula is a preventable childbirth injury that remains socially devastating for women in low-resource settings. Existing evidence on obstetric fistula stigma is largely derived from treatment centres and urban settings, leaving limited understanding of the lived experiences of women in underserved rural communities. This study addresses this knowledge gap by qualitatively exa…

IntroductionPolycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic disorders affecting women of reproductive age. Dendrobium officinale polysaccharides (DOP) have shown multiple pharmacological activities, but their therapeutic effects and underlying mechanisms in PCOS remain incompletely understood.MethodsA dehydroepiandrosterone (DHEA)-induced mouse model of PCOS was…

BackgroundSevere early-onset pregnancy-associated cholestasis with atypical features may reflect an intrahepatic cholestasis of pregnancy (ICP) component superimposed on underlying hepatobiliary disease. Evidence for bicyclol use during pregnancy is very limited.Case presentationA 34-year-old pregnant woman, developed palmoplantar pruritus and severe cholestasis at 15 weeks of gestation. She had …

Nature Communications, Published online: 21 August 2026; doi:10.1038/s41467-026-76891-9 Researchers found H5N1 bird flu can spread from pregnant mice to fetuses through the placenta and to newborns through milk, causing developmental delays, smaller size, and behavioral problems, highlighting pregnancy-related risks in mammals.

ObjectiveThis study aimed to explore the unique stress experiences and multidimensional stress dilemmas of infertile women during assisted reproductive technology (ART) treatment in the Chinese cultural context.MethodsFifteen infertile women undergoing ART treatment at a tertiary hospital in Chongqing were recruited for semi-structured face-to-face interviews. Guided by descriptive phenomenology,…

Overview New York, NY – August 20, 2026 – The Global Menopause Treatment Market size is expected to be worth around US$ 27.99 Billion by 2034, from US$ 15.78 Billion in 2024, growing at a CAGR of 5.9% during the forecast period from 2025 to 2034. North America held a dominant market position, capturing more […] The post Menopause Treatment Market Expected to Record 5.9% CAGR Through 2034 appeared…

research.ioresearch.io

Sign up to keep scrolling

Create your feed subscriptions, save articles, keep scrolling.

Already have an account?